Immunovaccine amends private placement

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date announced: 2/27/13 Type: Private placement To be raised: Up to C$2 million ($2 million) Shares: 6.1 million Price...